PortfoliosLab logoPortfoliosLab logo
LLY vs. BYRN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LLY vs. BYRN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eli Lilly and Company (LLY) and Byrna Technologies Inc. (BYRN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LLY achieves a 10.97% return, which is significantly higher than BYRN's -76.98% return. Over the past 10 years, LLY has outperformed BYRN with an annualized return of 33.16%, while BYRN has yielded a comparatively lower 4.88% annualized return.


LLY

1D
-2.33%
1M
2.38%
6M
12.13%
YTD
10.97%
1Y
50.94%
3Y*
40.33%
5Y*
39.60%
10Y*
33.16%

BYRN

1D
-1.90%
1M
-40.08%
6M
-77.79%
YTD
-76.98%
1Y
-83.17%
3Y*
-1.63%
5Y*
-28.95%
10Y*
4.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LLY vs. BYRN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LLY
Eli Lilly and Company
10.97%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%
BYRN
Byrna Technologies Inc.
-76.98%-41.72%350.86%-18.49%-41.27%-7.93%663.16%26.67%7.14%-30.00%

Correlation

The correlation between LLY and BYRN is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.04

Correlation (3Y)
Calculated over the trailing 3-year period

0.05

Correlation (5Y)
Calculated over the trailing 5-year period

0.08

Correlation (10Y)
Calculated over the trailing 10-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Feb 23, 2011

0.03

Fundamentals

Market Cap

LLY:

$1.12T

BYRN:

$87.68M

EPS

LLY:

$28.16

BYRN:

-$0.16

PS Ratio

LLY:

14.77

BYRN:

0.84

PB Ratio

LLY:

34.13

BYRN:

1.54

Total Revenue (TTM)

LLY:

$72.25B

BYRN:

$108.86M

Gross Profit (TTM)

LLY:

$59.75B

BYRN:

$57.17M

EBITDA (TTM)

LLY:

$32.97B

BYRN:

-$3.55M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LLY vs. BYRN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LLY
LLY Risk / Return Rank: 8080
Overall Rank
LLY Sharpe Ratio Rank: 8383
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7878
Sortino Ratio Rank
LLY Omega Ratio Rank: 7979
Omega Ratio Rank
LLY Calmar Ratio Rank: 8181
Calmar Ratio Rank
LLY Martin Ratio Rank: 8181
Martin Ratio Rank

BYRN
BYRN Risk / Return Rank: 33
Overall Rank
BYRN Sharpe Ratio Rank: 44
Sharpe Ratio Rank
BYRN Sortino Ratio Rank: 22
Sortino Ratio Rank
BYRN Omega Ratio Rank: 22
Omega Ratio Rank
BYRN Calmar Ratio Rank: 22
Calmar Ratio Rank
BYRN Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LLY vs. BYRN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Eli Lilly and Company (LLY) and Byrna Technologies Inc. (BYRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LLYBYRNDifference
Sharpe ratioReturn per unit of total volatility

+2.40

Sortino ratioReturn per unit of downside risk

+4.28

Omega ratioGain probability vs. loss probability

1.26

0.69

+0.57

Calmar ratioReturn relative to maximum drawdown

2.23

-0.99

+3.21

Martin ratioReturn relative to average drawdown

5.56

-1.65

+7.22

LLY vs. BYRN - Sharpe Ratio Comparison

The current LLY Sharpe Ratio is 1.33, which is higher than the BYRN Sharpe Ratio of -1.07. The chart below compares the historical Sharpe Ratios of LLY and BYRN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LLY vs. BYRN - Drawdown Comparison

The maximum LLY drawdown since its inception was -68.24%, smaller than the maximum BYRN drawdown of -92.51%. Use the drawdown chart below to compare losses from any high point for LLY and BYRN.


Loading charts...

Drawdown Indicators


LLYBYRNDifference

Max Drawdown

Largest peak-to-trough decline

-68.24%

-92.51%

+24.27%

Max Drawdown (1Y)

Largest decline over 1 year

-23.18%

-86.01%

+62.83%

Max Drawdown (3Y)

Largest decline over 3 years

-34.48%

-88.70%

+54.22%

Max Drawdown (5Y)

Largest decline over 5 years

-34.48%

-92.51%

+58.03%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

-92.51%

+58.03%

Current Drawdown

Current decline from peak

-3.80%

-88.70%

+84.90%

Average Drawdown

Average peak-to-trough decline

-19.19%

-52.50%

+33.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.27%

51.63%

-42.36%

Volatility

LLY vs. BYRN - Volatility Comparison

The current volatility for Eli Lilly and Company (LLY) is 9.93%, while Byrna Technologies Inc. (BYRN) has a volatility of 46.46%. This indicates that LLY experiences smaller price fluctuations and is considered to be less risky than BYRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LLYBYRNDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.93%

46.46%

-36.53%

Volatility (6M)

Calculated over the trailing 6-month period

27.64%

74.13%

-46.49%

Volatility (1Y)

Calculated over the trailing 1-year period

38.71%

82.31%

-43.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.51%

75.22%

-42.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.30%

96.16%

-65.86%

Dividends

LLY vs. BYRN - Dividend Comparison

LLY's dividend yield for the trailing twelve months is around 0.54%, while BYRN has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BYRN
Byrna Technologies Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.54%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

LLY vs. BYRN - Financials Comparison

This section allows you to compare key financial metrics between Eli Lilly and Company and Byrna Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
19.80B
16.39M
(LLY) Total Revenue
(BYRN) Total Revenue
Values in USD except per share items

LLY vs. BYRN - Profitability Comparison

The chart below illustrates the profitability comparison between Eli Lilly and Company and Byrna Technologies Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026April
79.0%
10.9%
Portfolio components
LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

BYRN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported a gross profit of 1.78M and revenue of 16.39M. Therefore, the gross margin over that period was 10.9%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

BYRN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported an operating income of -12.85M and revenue of 16.39M, resulting in an operating margin of -78.4%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.

BYRN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Byrna Technologies Inc. reported a net income of -10.09M and revenue of 16.39M, resulting in a net margin of -61.6%.


Frequently Asked Questions


LLY and BYRN have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BYRN has higher volatility (46.46%) compared to LLY (9.93%). In terms of maximum drawdown, LLY dropped -68.24% vs BYRN's -92.51%.

LLY currently has the higher Sharpe Ratio (1.33 vs -1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LLY and BYRN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer